New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Timescale Releases Third State of PostgreSQL Report
-
Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022
-
Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022
-
MBX Biosciences Receives Orphan Drug Designation for Lead Candidate MBX 2109 for the Treatment of Hypoparathyroidism
-
Embedded Tax Startup April Named Top 100 Early-Stage Company to Work For in 2022
-
PixieBrix Raises $5.4 Million Series A Led By NEA
-
Jarvis ML Named Top 100 Early-Stage Company to Work for In 2022
-
Rocketlane among 100 early-stage companies to work for in 2022
-
Everside Health Announces $164 Million in Growth Equity Funding from NEA and New Investors
-
Focused Energy Celebrates One Year of Achieving Key Fusion Energy Milestones
-
Form SC 13D Senti Biosciences, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Gossamer Bio Inc. (GOSS) Announces $120 Million Private Placement Financing
-
Gossamer Bio Announces $120 Million Private Placement Financing
-
New Wave Foods® Names Co-Founder Michelle Wolf CEO
-
VIPC’s Virginia Venture Partners Invests in Card Isle to Support Continued Growth of the Greeting Card Industry
-
VIPC’s Virginia Venture Partners Investment in Linebird Supports Continued Growth of Solution that Brings Unmanned Systems to High-Voltage Power Lines
-
VIPC’s Virginia Venture Partners Invests in Canopie to Provide Mental Health Resources to New and Expecting Mothers
-
VIPC’s Virginia Venture Partners Invests in Lynk to Provide Reliable Cellular Coverage via Satellites
-
X4 Pharmaceuticals (XFOR) Announces 50.93M Share Private Placement at $1.095
-
X4 Pharmaceuticals Announces $55 Million Private Placement Financing and Debt Facility Amendment Extending Interest-Only Period by up to 12 Months
-
Snowplow, the World's Leader in Data Creation for AI and BI, Closes $40M in Series B Funding
-
NEA Promotes Tiffany Le and Jess Ou to Principal
-
VIPC’s Virginia Venture Partners Invests in eLumin to Support Increased Access to Technology for All Students
-
Stack Capital Invests $7 Million USD Into Omio
-
Pionyr Immunotherapeutics to Present on Myeloid Tuning Platform and TREM1 Targeting Antibody Program at the Tumor Myeloid-Directed Therapies Summit
-
Alternative Investment Platform Yieldstreet Partners with Wonder Group, the Company Redefining At-Home Dining and Food Delivery, to Offer Investors Access to the Startup’s Series B Funding Round
-
Metacrafters.io Raises $4.5M for Web3 Developers with Multichain Grants from Solana, Flow, Avalanche, and Polygon Foundations
-
Kira Learning Announces $6 Million Seed Round Financing Led by NEA and Dr. Andrew Ng’s AI Fund
-
4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing
-
4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing
-
Code Biotherapeutics Raises Upsized and Oversubscribed $75 Million in Series A Financing to Develop Therapies for Debilitating Genetic Diseases
-
Form SC 13D/A IonQ, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D/A GENOCEA BIOSCIENCES, Filed by: New Enterprise Associates 16, L.P.
-
New Wave Foods Welcomes Taylor Crown as New Board Member
-
Pionyr Immunotherapeutics’ Phase 1a Study of TREM2-targeting Antibody PY314 for the Treatment of Solid Tumors Featured at ASCO 2022
-
Assembled Raises $51 Million led by NEA to Accelerate Workforce Management Platform
-
Stablix Appoints Eddine Saiah Chief Scientific Officer and Expands Leadership Team
-
Form SC 13D/A IMARA Inc. Filed by: New Enterprise Associates 14, L.P.
-
VIPC’s Virginia Venture Partners Invests in Magazine Jukebox, Inc. to Provide Digital Alternative to Traditional Magazine Displays
-
VIPC’s Virginia Venture Partners Invests in Magazine Jukebox, Inc. to Provide Digital Alternative to Traditional Magazine Displays
-
AviadoBio Presents Preclinical Data at ASGCT 2022 Demonstrating that AVB-101 Represents a Novel and Promising Approach to the Treatment of Frontotemporal Dementia
-
AviadoBio Presents Preclinical Data at ASGCT 2022 Demonstrating that AVB-101 Represents a Novel and Promising Approach to the Treatment of Frontotemporal Dementia
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates
-
Timescale Announces OpenTelemetry Tracing Support for Promscale
-
Celcuity (CELC) Announces $100M Private Placement
-
Celcuity Inc. Announces $100 Million Private Placement
-
AviadoBio Announces Formation of Scientific Advisory Board
-
AviadoBio Announces Formation of Scientific Advisory Board

